Back to top

Image: Bigstock

Top Ranked Value Stocks to Buy for May 5th

Read MoreHide Full Article

Here are four stocks with buy rank and strong value characteristics for investors to consider today, May 5th:

Emerald Holding, Inc. (EEX - Free Report) : This operator of business-to-business trade shows has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 1.1% over the last 60 days.

Emerald has a price-to-earnings ratio (P/E) of 2.32, compared with 15.60 for the industry. The company possesses a Value Score of A.

GAIN Capital Holdings, Inc. (GCAP - Free Report) : This provider of trading services and solutions has a Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising more than 100% over the last 60 days.

GAIN Capital has a price-to-earnings ratio (P/E) of 2.42, compared with 13.10 for the industry. The company possesses a Value Score of B.

Banco BBVA Argentina S.A. (BBAR - Free Report) : This provider of various banking products and services has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 8.8% over the last 60 days.

Banco BBVA Argentina has a price-to-earnings ratio (P/E) of 1.57, compared with 11.60 for the industry. The company possesses a Value Score of A.

The Allstate Corporation (ALL - Free Report) : This provider of property and casualty and other insurance products has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 5.2% over the last 60 days.

Allstate has a price-to-earnings ratio (P/E) of 9.19, compared with 10.70 for the industry. The company possesses a Value Score of A.

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>